Kahn Brothers Group
KAHN BROTHERS GROUP INC · NEW YORK, NY · Dönem sonu: 30 Eyl 2026 · SEC'e bildirim: 16 Kas 2026 · SEC kaynağını aç ↗Değer Yatırımcısı
Portföy Getirisi (1Y)——
Portföy BüyüklüğüFonun SEC’e bildirdiği ABD hisse portföyünün toplam değeri.$601.8M2026 Q3
Pozisyon48
İlk 10 Hissenin AğırlığıPortföyün yüzde kaçı en büyük 10 hissede. Yüksekse fon az sayıda hisseye odaklı.76.2%
Portföy Büyüklüğü Geçmişi
Çeyreklik Geçmiş · 40 Çeyrek
| Çeyrek | Bildirim | Pozisyon | Toplam Değer | Devir %Devir = (açılan pozisyonların değeri + kapatılan pozisyonların önceki değeri + ortak pozisyonlarda |adet değişimi| × fiyat) / iki çeyreğin ortalama portföy değeri. Fiyat hareketi devir sayılmaz; herhangi bir işlem olan çeyrek asla %0 değildir. | İlk 10 |
|---|---|---|---|---|---|
| 2026 Q3 | 2026-11-16 | 48 | $601.8M | 10.8% | C, BAYRY, FLG, GOOG, DIS, Z, MRK, BP, IDT, SEG |
| 2026 Q2✎ düzeltme uygulandı | 2026-08-14 | 48 | $632.7M | 14.1% | C, BAYRY, FLG, GOOG, Z, OGN, DIS, MRK, MBI, SEG |
| 2026 Q1 | 2026-05-08 | 48 | $564.1M | 21.9% | C, BAYRY, FLG, DIS, GOOG, SEB, OGN, BP, MRK, Z |
| 2025 Q4 | 2026-02-12 | 54 | $564.7M | 3.9% | C, BAYRY, FLG, MRK, DIS, GOOG, BP, SEB, OGN, IDT |
| 2025 Q3 | 2025-11-12 | 53 | $531.8M | 16.9% | C, BAYRY, FLG, DIS, OGN, BP, MRK, GOOG, SEB, IDT |
| 2025 Q2 | 2025-08-14 | 50 | $497.9M | 21.8% | C, BAYRY, DIS, FLG, MRK, BP, OGN, IDT, BMY, GSK |
| 2025 Q1 | 2025-05-15 | 55 | $494.5M | 14.5% | C, FLG, MRK, BAYRY, BP, OGN, BMY, DIS, GSK PLC, SEB |
| 2024 Q4 | 2025-02-14 | 52 | $460.4M | 31.7% | C, MRK, DIS, BMY, BP, FLG, GSK PLC, AGO, OGN, BAYRY |
| 2024 Q3 | 2024-11-13 | 53 | $580.6M | 29.5% | C, MRK, BP, NYCBEUR, BAYRY, GSK PLC, BMY, DIS, OGN, PFE |
| 2024 Q2 | 2024-08-14 | 52 | $595.0M | 19.8% | C, MRK, BP, GSK PLC, NYCBEUR, OGN, BMY, BAYRY, MBI, SEB |
| 2024 Q1 | 2024-05-15 | 53 | $674.4M | 12.8% | AGO, MRK, C, BP, GSK PLC, BMY, MBI, PTEN, SEB, PFE |
| 2023 Q4 | 2024-02-13 | 43 | $634.8M | 4.1% | AGO, MRK, NYCBEUR, C, BP, GSK PLC, BMY, PTEN, SEB, VOXX INTERNATIONAL |
| 2023 Q3 | 2023-11-13 | 43 | $640.9M | 2.6% | NYCBEUR, BP, MRK, AGO, PTEN, C, BMY, GSK PLC, SEB, PFE |
| 2023 Q2 | 2023-08-09 | 43 | $682.1M | 3.8% | MRK, NYCBEUR, BP, BMY, AGO, C, PTEN, GSK PLC, MBI, PFE |
| 2023 Q1 | 2023-05-12 | 45 | $694.7M | 4.8% | BP, MRK, BMY, NYCBEUR, AGO, C, PTEN, GSK PLC, MBI, PFE |
| 2022 Q4 | 2023-02-15 | 45 | $759.6M | <0.1% | AGO, MRK, BP, PTEN, BMY, MBI, PFE, C, NYCBEUR, GSK PLC |
| 2022 Q3 | 2022-11-15 | 45 | $641.7M | 4.0% | BMY, BP, AGO, MRK, PTEN, NYCBEUR, C, PFE, MBI, GSK PLC |
| 2022 Q2 | 2022-08-10 | 45 | $742.7M | 5.1% | PTEN, AGO, BMY, MRK, BP, GSK PLC, MBI, PFE, NYCBEUR, C |
| 2022 Q1 | 2022-05-02 | 46 | $787.6M | 38.9% | PTEN, AGO, MBI, BMY, BP, GSK PLC, MRK, PFE, NYCBEUR, C |
| 2021 Q4 | 2022-01-25 | 43 | $728.0M | 2.7% | MBI, AGO, GSK PLC, PFE, BP, NYCBEUR, BMY, MERCK, CITIGROUP, PTEN |
| 2021 Q3 | 2021-11-01 | 43 | $710.3M | 4.1% | AGO, MBI, BP, NYCBEUR, CITIGROUP, PTEN, MERCK, GSK PLC, BMY, PFE |
| 2021 Q2 | 2021-08-04 | 43 | $698.3M | 11.2% | AGO, CITIGROUP, BMY, PTEN, BP, MERCK, MBI, NYCBEUR, GSK PLC, SEB |
| 2021 Q1 | 2021-05-07 | 42 | $646.1M | 10.6% | AGO, CITIGROUP, NYCBEUR, MERCK, BMY, MBI, BP, GSK PLC, PTEN, SEB |
| 2020 Q4 | 2021-02-11 | 42 | $573.3M | 10.4% | MERCK, BMY, CITIGROUP, AGO, GSK PLC, NYCBEUR, VOXX INTERNATIONAL, BP, MBI, SEB |
| 2020 Q3 | 2020-11-06 | 42 | $527.5M | 9.3% | MERCK, BMY, GSK PLC, NYCBEUR, CITIGROUP, AGO, BP, SEB, MBI, VOXX INTERNATIONAL |
| 2020 Q2 | 2020-08-03 | 47 | $591.8M | 7.7% | MERCK, GSK PLC, BMY, NYCBEUR, CITIGROUP, BP, AGO, SEB, MBI, BB |
| 2020 Q1 | 2020-05-11 | 48 | $546.7M | 4.0% | MERCK, GSK PLC, BMY, NYCBEUR, BP, CITIGROUP, AGO, MBI, SEB, PFE |
| 2019 Q4 | 2020-01-27 | 47 | $824.7M | 14.3% | MERCK, CITIGROUP, AGO, GSK PLC, BMY, NYCBEUR, BP, SEB, MBI, BB |
| 2019 Q3✎ düzeltme uygulandı | 2019-11-04 | 48 | $797.6M | 51.6% | MERCK, CITIGROUP, AGO, NYCBEUR, GSK PLC, BP, SEB, BMY, MBI, BB |
| 2019 Q2 | 2019-08-05 | 44 | $799.9M | 36.0% | MERCK, CITIGROUP, BP, AGO, GSK PLC, SEB, NYCBEUR, MBI, BMY, BB |
| 2019 Q1 | 2019-05-06 | 32 | $640.0M | 11.5% | MERCK, BP, CITIGROUP, AGO, GSK PLC, NYCBEUR, BB, MBI, SEB, BMY |
| 2018 Q4 | 2019-01-29 | 31 | $554.7M | 3.4% | MERCK, BP, CITIGROUP, AGO, GSK PLC, NYCBEUR, MBI, BB, NYT, SEB |
| 2018 Q3 | 2018-10-30 | 31 | $651.2M | 5.0% | CITIGROUP, BP, MERCK, AGO, BB, GSK PLC, MBI, NYCBEUR, NYT, SEB |
| 2018 Q2 | 2018-08-06 | 31 | $628.4M | 4.6% | BP, CITIGROUP, MERCK, GSK PLC, NYT, AGO, BB, MBI, NYCBEUR, SEB |
| 2018 Q1 | 2018-05-01 | 31 | $627.7M | 6.8% | CITIGROUP, BP, NYT, BB, MERCK, GSK PLC, AGO, MBI, SEB, NYCBEUR |
| 2017 Q4 | 2018-01-25 | 31 | $636.6M | 5.4% | CITIGROUP, BP, NYT, MERCK, BB, GSK PLC, AGO, SEB, MBI, PTEN |
| 2017 Q3✎ düzeltme uygulandı | 2017-11-03 | 34 | $654.5M | 9.9% | CITIGROUP, NYT, MERCK, BP, BB, GSK PLC, MBI, SEB, AGO, VOXX INTERNATIONAL |
| 2017 Q2 | 2017-08-08 | 34 | $655.8M | 8.7% | CITIGROUP, NYT, MERCK, BP, GSK PLC, BB, MBI, HO1, SEB, AGO |
| 2017 Q1 | 2017-05-08 | 35 | $581.4M | 9.7% | CITIGROUP, MERCK, NYT, BP, GSK PLC, HO1, MBI, BB, SEB, NYCBEUR |
| 2016 Q4 | 2017-01-31 | 35 | $592.1M | 30.6% | CITIGROUP, MERCK, NYT, BP, HO1, MBI, NYCBEUR, SEB, GSK PLC, BB |
Adetler bölünme düzeltmeli (split-adjusted). Elde tutma süresi, en son çeyrekle biten kesintisiz çeyrek sayısından hesaplanır; 10 yıl üstü ">10 Yıl" olarak gösterilir.
Benzer portföyler
Son çeyrekte tutulan hisselerin Jaccard benzerliğine göre en yakın beş usta yatırımcı (gece hesaplanır).
| Fon | Örtüşme | Ortak hisseler |
|---|---|---|
| Gardner Russo & Quinn (Tom Russo) | 8.1% | CVX, DIS, MSFT, PEP, PG, AAPL, MRK, GOOG +2 |
| Dodge & Cox | 7.8% | BMY, CVX, DIS, HLN, IBM, MSFT, PFE, PG +6 |
| Semper Augustus Investments | 7.6% | CVX, DIS, MSFT, AAPL, MRK, GOOG, XOM |
| Capital Research Global Investors | 6.8% | CSX, CVX, MSFT, PNC, PEP, PG, PEG, VZ +6 |
| Chou Associates (Francis Chou) | 6.8% | C, MBI, BAC, AAPL, GOOG |
2026-Q2 çeyrek raporunu oku · 13F Bildirim Takvimi
13F verisi çeyrek sonu pozisyonlarını gösterir, 45 güne kadar gecikmelidir ve yalnızca ABD borsalarındaki uzun (long) pozisyonları kapsar; açığa satışlar, türevler ve ABD dışı varlıklar bildirilmez.